Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02587962 |
Title | Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Medivir |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | United States | Details | |
Cedars-Sinai Medical Center | Los Angeles | California | 90048 | United States | Details | |
UCLA Dept of Medicine-Hematology/Oncology | Santa Monica | California | 90404 | United States | Details | |
Mid Florida Hematology and Oncology Center | Orange City | Florida | 32763 | United States | Details | |
The Sidney Kimmel Comprehensive Cancer Center at John Hopkins | Baltimore | Maryland | 21287 | United States | Details | |
Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States | Details | |
Thomas Jefferson University Sidney Kimmel Cancer Center | Philadelphia | Pennsylvania | 19107 | United States | Details | |
Mary Crowley Cancer Research | Dallas | Texas | 75251 | United States | Details | |
MD Anderson Cancer Center, The University of Texas | Houston | Texas | 77030 | United States | Details |